C - Chemistry – Metallurgy – 12 – N
Patent
C - Chemistry, Metallurgy
12
N
C12N 15/864 (2006.01) A61K 39/395 (2006.01) C07K 16/10 (2006.01) C12N 7/01 (2006.01) C12N 15/13 (2006.01) C12P 21/02 (2006.01) A61K 48/00 (2006.01)
Patent
CA 2481813
The present invention relates generally to the use of recombinant adeno- associated viruses (rAAV) for gene delivery and more specifically to the use of rAAV to deliver antibody genes to target cells in mammals. Administration of rAAV encoding antibodies that neutralize the HIV-1 virus is exemplified.
L'invention concerne en général l'utilisation de virus recombinants adéno-associés (rAAV) destinés au transfert génique et plus particulièrement à l'utilisation de ces rAAV afin de transférer des gènes d'anticorps dans des cellules cibles chez des mammifères. L'invention concerne également l'administration de rAAV codant des anticorps qui neutralisent le virus HIV-1.
Clark Kelly Reed
Johnson Philip R. Jr.
Children's Hospital Inc.
Nationwide Children's Hospital Inc.
Smart & Biggar
LandOfFree
Antibody gene transfer and recombinant aav therefor does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Antibody gene transfer and recombinant aav therefor, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antibody gene transfer and recombinant aav therefor will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1726222